Hormone replacement therapy after breast cancer

被引:0
|
作者
Pertynski, T [1 ]
Kubasiewicz, M [1 ]
Wojciechowski, A [1 ]
机构
[1] Polish Mother Mem Hosp, Dept Menopause, PMMH Res Inst, Lodz, Poland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The authors have performed a thorough review of medical literature, attempting to find reports on using hormone replacement therapy (HRT) in women after breast cancer [1,4,5,7,8,9,11,12,15,18]. The risk factors for mammary cancer include: genetic, reproductive, body and exogenous. Among the exogenous factors, oral contraceptives and HRT are the ones most frequently referred to. Following meta-analyses, the administration of HRT before breast cancer provides for a relative risk of 1.01 - 1.07 in a short-term use, rising to 1.09 - 1.30 in a long-term use. Regarding the own and others' data, the authors estimate that chemotherapy, applied after breast cancer, develops menopause in its full clinical picture. The pathologies of the period, such as cardiovascular diseases, osteoporosis, sexual disorders, Alzheimer disease, together with a decreased quality of life in general, stand for much more serious threats than the risk of breast cancer recurrence. The authors claim then that an appropriate hormone therapy should administered to women surviving breast cancer in order to eliminate or reduce the troublesome symptoms of menopause, the women to be thoroughly instructed of potential advantages and dangers of HRT.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 50 条
  • [31] Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality
    Durna, EM
    Wren, BG
    Heller, GZ
    Leader, LR
    Sjoblorn, P
    Eden, JA
    MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (07) : 347 - 351
  • [32] Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality
    Hayes, TM
    Underhill, CR
    Clarke, K
    Tattersall, MHN
    MEDICAL JOURNAL OF AUSTRALIA, 2003, 178 (08) : 412 - 413
  • [33] Hormone replacement therapy, breast and endometrial cancer
    LaVecchia, C
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1996, 5 (05) : 414 - 416
  • [34] Hormone replacement therapy and risk of breast cancer
    Ortmann, O
    Schulz, KD
    Diedrich, K
    GYNAKOLOGE, 1998, 31 (10): : 885 - 890
  • [35] Hormone-replacement therapy and breast cancer
    Marsden, J
    LANCET ONCOLOGY, 2002, 3 (05): : 303 - 311
  • [36] Hormone replacement therapy and breast cancer risk
    Gambrell, RD
    ARCHIVES OF FAMILY MEDICINE, 1996, 5 (06) : 341 - 348
  • [37] Risk of breast cancer with hormone replacement therapy
    Michels, KB
    MIDLIFE HEALTH - CURRENT CONCEPTS AND CHALLENGES FOR THE FUTURE, 2002, 1229 : 135 - 141
  • [38] Hormone replacement therapy and risk of breast cancer
    Stadel, BV
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18): : 2360 - 2361
  • [39] Hormone replacement therapy and breast cancer risk
    Koukoulis, GN
    YOUNG WOMAN AT THE RISE OF THE 21ST CENTURY: GYNECOLOGICAL AND REPRODUCTIVE ISSUES IN HEALTH AND DISEASE, 2000, 900 : 422 - 428
  • [40] Hormone replacement therapy and risk of breast cancer
    Ortmann O.
    Treeck O.
    Inwald E.C.
    Emons G.
    Tempfer C.
    best practice onkologie, 2019, 14 (12) : 570 - 579